Liquid biopsy is a new, minimally invasive technology for detection of disease biomarkers without the need for costly or invasive procedures. In this video, Dr. Brian Adams talks about the role of miRNA from exosomes as potential circulating biomarkers, challenges and recommended techniques for isolating these tiny microvesicles. Liquid biopsies promise to revolutionize the way serious diseases are detected and monitored.
Tagged with: Brian Adams Liquid Biopsy miRNA
Related Articles
ReNeuron breakthrough – Exosome tech delivers therapeutic proteins to hard to access region of brain
October 12, 2021
Exosomes & EVs – Isolation, Characterization, Machine Learning for RNA diagnostics
September 24, 2021